Docetaxel-PM

DRUG2 trials

Sponsors

Samyang Biopharmaceuticals Corporation, Sung Yong Oh

Conditions

Esophagus Squamous Cell Carcinoma (SCC)Head and Neck Squamous Cell CarcinomaMetastatic Cancer

Phase 2

Study to Evaluate the Efficacy and Safety of Docetaxel Polymeric Micelle (PM) in Recurrent or Metastatic HNSCC

Samyang Biopharmaceuticals CorporationHead and Neck Squamous Cell Carcinoma

Start: 2015-10-31End: 2020-09-30Target: 31Updated: 2017-05-01

Docetaxel-polymeric Micelles(PM) and Oxaliplatin for Esophageal Carcinoma

Sung Yong OhEsophagus Squamous Cell Carcinoma (SCC), Metastatic Cancer

Start: 2018-06-01End: 2021-03-30Target: 38Updated: 2018-07-17